Who Paid My Doc
Rangasamy Ramanathan
Neonatal-Perinatal Medicine West Hollywood, CA Medical Doctor
NPI 1891890760 CMS profile 85713
8700 Beverly Blvd Ste 4221, West Hollywood, CA 90048
General payments
$96,036
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$163,560
Through program year 2025, Rangasamy Ramanathan of West Hollywood, CA is reported in the CMS Open Payments database as having received $96,036 across 145 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $163,560 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Neonatal-Perinatal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $6,005 | 8 | |
| 2024 | General | $7,936 | 5 | |
| 2023 | General | $21,250 | 26 | |
| 2022 | General | $2,246 | 7 | |
| 2021 | General | $9,125 | 6 | |
| 2020 | General | $14,510 | 27 | |
| 2019 | General | $34,965 | 66 |
Beside peers
- Rangasamy Ramanathan
- Neonatal-Perinatal Medicine median
- Middle half of Neonatal-Perinatal Medicine
- National median
In program year 2025, general payments to Rangasamy Ramanathan were reported at $6,005. Among 879 Neonatal-Perinatal Medicine profiles paid that year, the median was $77 and the middle half received between $26 and $145.
Show as a table
| Year | Rangasamy Ramanathan | Neonatal-Perinatal Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $34,965 | $70 | $22–$125 | $163 |
| 2020 | $14,510 | $39 | $18–$108 | $114 |
| 2021 | $9,125 | $49 | $18–$122 | $132 |
| 2022 | $2,246 | $47 | $21–$149 | $149 |
| 2023 | $21,250 | $49 | $23–$140 | $160 |
| 2024 | $7,936 | $65 | $24–$132 | $164 |
| 2025 | $6,005 | $77 | $26–$145 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
145 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neonatal-Perinatal Medicine in California
Neil Finer
Neonatal-Perinatal Medicine · San Diego, CA
Janene Fuerch
Neonatal-Perinatal Medicine · Palo Alto, CA
Denise Suttner
Neonatal-Perinatal Medicine · San Diego, CA
Mitchell Goldstein
Neonatal-Perinatal Medicine · Northridge, CA
Donald Null
Neonatal-Perinatal Medicine · Sacramento, CA
Michel Mikhael
Neonatal-Perinatal Medicine · Orange, CA
Related records
Neonatal-Perinatal Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Neonatal-Perinatal Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.